A+ R A-

IWWM-10 Session 12: Oral Presentations of Selected Abstracts II

The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 12: Oral Presentations of Selected Abstracts II

Session Chairs: Judith Trotman (Australia) and Ranjana Advani (USA)

Development of novel IRAK1 inhibitors for treatment of WM X. Liu (USA)

CANOMAD: Clinical, Biological, Electrophysiological and Treatment Analysis M. LeCann (France)

Ibrutinib Therapy in WM: Outcomes Outside a Clinical Trial J. Abeykoon (USA)

Phase II Study of Idelalisib and Obinutuzumab in relapsed/refractory WM C.Tomowiak (France)

Phase II Study of Bendamustine, Rituximab, Bortezomib in relapsed/refractory WM G. Benevolo (Italy)

New York 2018 (IWWM-10)

New York 2018 Conference Chairs

  • Jorge Castillo, MD (Dana-Farber)
  • Richard Furman, MD (Cornell University)
  • M. Lia Palomba, MD (Memorial Sloan Kettering)
  • Steven Treon, MD, PhD (Dana-Farber)
  • Chris Patterson - Secretariat (Dana-Farber)

The New York 2018 Scientific Committee members:

Ranjana Advani, MD (USA)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Giampaolo Merlini MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Marvin Stone, MD (USA)
Marzia Varretoni, MD (Italy)

Registration for this meeting is now closed.

New York 2018 (IWWM-10) was held at the New York Marriott Downtown in New York City.

New York Marriott Downtown

Click here to download our New York City visitor's guide